Vanderbilt Memory News Today

Alzheimer's affects more than 6 million Americans, but the cause and cure are still unknown. That's why Vanderbilt is conducting a study to learn more, with a special focus on one group.

Also: Digital health firm adds to portfolio, study finds more heart failure in rural areas

Vanderbilt is looking for people to take part in a new Alzheimer's study to research early drivers of the disease.

The Vanderbilt Memory and Alzheimer's Center is recruiting individuals age 50 and older to participate in a study researching early drivers of Alzheimer's disease.

Images with hints of duplication or manipulation have scientists, medical journals reviewing findings about origins of the disease.

Medical center will lead data aggregation initiative to support future drug research, development

Jun 1, 2021 Associations seen with many CSF measures, but not beta-amyloid Aortic stiffening was associated with cerebrospinal fluid (CSF) markers of neurodegeneration and Alzheimer’s disease, a cross-sectional study found. “Among our oldest participants, age 74 years and older, greater aortic stiffening is associated with in vivo biomarker evidence of neuroinflammation, tau phosphorylation, synaptic dysfunction, and neurodegeneration, but not amyloidosis,” wrote Angela Jefferson, PhD, o...

 E-Mail IMAGE: This image shows the close relationship between phospholipase D3 and the pathological hallmarks of Alzheimers disease in tissue from the temporal lobe of a human brain. Phospholipase D3, which is... view more  Credit: Matthew Schrag A rare and controversial mutation in the phospholipase D3 (PLD3) protein - previously linked to Alzheimers disease - interferes with PLD3s vital recycling function inside neurons. Matthew Schrag of Vanderbilt University Medical Center and co...